Sophia Randolph
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
-
Alx Oncology Holdings Inc (ALXO)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Alx Oncology Holdings Inc (ALXO) | M.D., Ph.D. Former Chief Medical Officer | $468,922 | $3,530,138 |
| 2023 | Alx Oncology Holdings Inc (ALXO) | M.D., Ph.D. Former Chief Medical Officer | $510,000 | $1,374,892 |
| 2022 | Alx Oncology Holdings Inc (ALXO) | M.D., Ph.D. Chief Medical Officer | $471,330 | $2,084,570 |
| 2021 | Alx Oncology Holdings Inc (ALXO) | M.D., Ph.D. Chief Medical Officer | $453,200 | $4,751,470 |
| 2020 | Alx Oncology Holdings Inc (ALXO) | M.D., Ph.D. Chief Medical Officer | $397,588 | $2,757,365 |
| 2019 | Alx Oncology Holdings Inc (ALXO) | M.D., Ph.D. Chief Medical Officer | $351,100 | $497,334 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.